Estefano Muñoz-Moya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Estefano Muñoz-Moya has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Gantenbein
Tissue Engineering for Orthopaedics & Mechanobiology, Bone & Joint Program, Department for BioMedical Research (DBMR), Medical Faculty University of Bern Bern Switzerland
3 shared publications - Jérôme Noailly
BCN MedTech, Department of Engineering Universitat Pompeu Fabra Barcelona Spain
3 shared publications - Carlos Ruiz Wills
BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain
2 shared publications - Christine Lyn Le Maitre
Division of Clinical Medicine, School of Medicine and Population Health University of Sheffield Sheffield UK
2 shared publications - Gemma Piella
BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain
2 shared publications Jérôme Noailly
BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 3 October 2026
- Published by Elsevier in Materials & Design
- Vol. 271
Orthotropy and aging effects on the nanomechanical properties of Perumytilus purpuratus nacre
- 3 October 2026
- Published by Elsevier in Materials & Design
- Vol. 271
Open AccessOrthotropy and aging effects on the nanomechanical properties of Perumytilus purpuratus nacre
- Open Access
- 10 July 2026
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 285, 109531
Novel finite element fully coupled multi-species mechano-transport simulations approach of the Intervertebral Disc
- 10 July 2026
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 285, 109531
Open AccessNovel finite element fully coupled multi-species mechano-transport simulations approach of the Intervertebral Disc
- Top Cited PapersOpen Access
Complex Mechanical Loading and Pro‐Inflammatory Cytokines in Intervertebral Disc Degeneration
Background: Intervertebral disc (IVD) degeneration is a major contributor to low back pain, yet its initiating factors remain unclear. While the individual effects of pro‐inflammatory cytokines and mechanical loading on IVDs have been studied, their combined impact is poorly understood. This study investigated how dynamic compression and torsion interact with interleukin‐1 beta (IL‐1β) and its inhibitor, interleukin‐1 receptor antagonist (IL‐1Ra), using bovine IVDs in an ex vivo organ culture system. Methods: Whole bovine caudal IVDs were cultured for one week in a custom bioreactor applying diurnal dynamic compression (0.1–0.5 MPa) and torsion (±6°) under three media conditions: physiological, catabolic (10 ng/mL IL‐1β), and inhibitory (10 ng/mL IL‐1Ra). Static compression (0.1 MPa) served as control. 3 T magnetic resonance imaging (MRI) was used pre‐ and post‐culture for imaging and segmentation using 3DSlicer. Subject‐personalized finite element (FE) models were generated via morphing algorithms and coupled with a parallel network (PN) model to analyze metabolite transport and its impact on gene expression. Outcomes included disc height, glycosaminoglycan (GAG) content, qPCR, and cell metabolic activity. Results & Conclusions: Degenerative changes were detected in all treatment groups. Results of decreased disc height, hydration, and ACAN expression, alongside increased MMP‐13, indicated that the applied loading was supraphysiological and induced catabolic responses. IL‐1Ra, at the given dose, did not counteract degeneration. MRI‐based FE modeling effectively captured patterns of tissue consolidation and degeneration, providing valuable insights into IVD responses under combined mechanical and inflammatory stress. This integrative platform highlights the importance of modeling complex IVD environments and may inform the design of improved anti‐catabolic therapies.
Top Cited PapersOpen AccessComplex Mechanical Loading and Pro‐Inflammatory Cytokines in Intervertebral Disc Degeneration
Background: Intervertebral disc (IVD) degeneration is a major contributor to low back pain, yet its initiating factors remain unclear. While the individual effects of pro‐inflammatory cytokines and mechanical loading on IVDs have been studied, their combined impact is poorly understood. This study investigated how dynamic compression and torsion interact with interleukin‐1 beta (IL‐1β) and its inhibitor, interleukin‐1 receptor antagonist (IL‐1Ra), using bovine IVDs in an ex vivo organ culture system. Methods: Whole bovine caudal IVDs were cultured for one week in a custom bioreactor applying diurnal dynamic compression (0.1–0.5 MPa) and torsion (±6°) under three media conditions: physiological, catabolic (10 ng/mL IL‐1β), and inhibitory (10 ng/mL IL‐1Ra). Static compression (0.1 MPa) served as control. 3 T magnetic resonance imaging (MRI) was used pre‐ and post‐culture for imaging and segmentation using 3DSlicer. Subject‐personalized finite element (FE) models were generated via morphing algorithms and coupled with a parallel network (PN) model to analyze metabolite transport and its impact on gene expression. Outcomes included disc height, glycosaminoglycan (GAG) content, qPCR, and cell metabolic activity. Results & Conclusions: Degenerative changes were detected in all treatment groups. Results of decreased disc height, hydration, and ACAN expression, alongside increased MMP‐13, indicated that the applied loading was supraphysiological and induced catabolic responses. IL‐1Ra, at the given dose, did not counteract degeneration. MRI‐based FE modeling effectively captured patterns of tissue consolidation and degeneration, providing valuable insights into IVD responses under combined mechanical and inflammatory stress. This integrative platform highlights the importance of modeling complex IVD environments and may inform the design of improved anti‐catabolic therapies.
- Open Access
- 19 November 2024
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 259, 108493
A porohyperelastic scheme targeted at High-Performance Computing frameworks for the simulation of the intervertebral disc
- 19 November 2024
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 259, 108493
Open AccessA porohyperelastic scheme targeted at High-Performance Computing frameworks for the simulation of the intervertebral disc
- 3 October 2024
- Published by Springer Nature
- p. 572-582
Pixel2Mechanics: Automated Biomechanical Simulations of High-Resolution Intervertebral Discs from Anisotropic MRIs
- 3 October 2024
- Published by Springer Nature
- p. 572-582
Pixel2Mechanics: Automated Biomechanical Simulations of High-Resolution Intervertebral Discs from Anisotropic MRIs
- Top Cited PapersOpen Access
Cartilaginous endplates: A comprehensive review on a neglected structure in intervertebral disc research
The cartilaginous endplates (CEP) are key components of the intervertebral disc (IVD) necessary for sustaining the nutrition of the disc while distributing mechanical loads and preventing the disc from bulging into the adjacent vertebral body. The size, shape, and composition of the CEP are essential in maintaining its function, and degeneration of the CEP is considered a contributor to early IVD degeneration. In addition, the CEP is implicated in Modic changes, which are often associated with low back pain. This review aims to tackle the current knowledge of the CEP regarding its structure, composition, permeability, and mechanical role in a healthy disc, how they change with degeneration, and how they connect to IVD degeneration and low back pain. Additionally, the authors suggest a standardized naming convention regarding the CEP and bony endplate and suggest avoiding the term vertebral endplate. Currently, there is limited data on the CEP itself as reported data is often a combination of CEP and bony endplate, or the CEP is considered as articular cartilage. However, it is clear the CEP is a unique tissue type that differs from articular cartilage, bony endplate, and other IVD tissues. Thus, future research should investigate the CEP separately to fully understand its role in healthy and degenerated IVDs. Further, most IVD regeneration therapies in development failed to address, or even considered the CEP, despite its key role in nutrition and mechanical stability within the IVD. Thus, the CEP should be considered and potentially targeted for future sustainable treatments.
Top Cited PapersOpen AccessCartilaginous endplates: A comprehensive review on a neglected structure in intervertebral disc research
The cartilaginous endplates (CEP) are key components of the intervertebral disc (IVD) necessary for sustaining the nutrition of the disc while distributing mechanical loads and preventing the disc from bulging into the adjacent vertebral body. The size, shape, and composition of the CEP are essential in maintaining its function, and degeneration of the CEP is considered a contributor to early IVD degeneration. In addition, the CEP is implicated in Modic changes, which are often associated with low back pain. This review aims to tackle the current knowledge of the CEP regarding its structure, composition, permeability, and mechanical role in a healthy disc, how they change with degeneration, and how they connect to IVD degeneration and low back pain. Additionally, the authors suggest a standardized naming convention regarding the CEP and bony endplate and suggest avoiding the term vertebral endplate. Currently, there is limited data on the CEP itself as reported data is often a combination of CEP and bony endplate, or the CEP is considered as articular cartilage. However, it is clear the CEP is a unique tissue type that differs from articular cartilage, bony endplate, and other IVD tissues. Thus, future research should investigate the CEP separately to fully understand its role in healthy and degenerated IVDs. Further, most IVD regeneration therapies in development failed to address, or even considered the CEP, despite its key role in nutrition and mechanical stability within the IVD. Thus, the CEP should be considered and potentially targeted for future sustainable treatments.